SiteOne Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The companys lead therapeutic candidates include ST-2427 Intravenous, for post-operative pain; ST-SubQ Subcutaneous and ST-Oral, for acute and chronic pain; ST-Topical, for ocular pain and local anesthetic. Its platform NaV1.7 is a voltage-gated sodium channel for generation and conduction of action potentials in sensory neurons. The company operates research laboratory in South San Francisco. SiteOne is headquartered in Bozeman, Montana, the US.

SiteOne Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SiteOne Therapeutics Raises USD15 Million in Series B Financing 10
SiteOne Therapeutics Raises Funds through Venture Financing 12
SiteOne Therapeutics Raises USD1.5 Million in Initial Round of Venture Financing 13
Partnerships 14
SiteOne Therapeutics Enters into R&D Agreement with Amgen 14
SiteOne Therapeutics Inc - Key Competitors 15
SiteOne Therapeutics Inc - Key Employees 16
SiteOne Therapeutics Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Sep 12, 2018: SiteOne Therapeutics names Scott Braunstein as Board Director 18
Sep 06, 2017: SiteOne Therapeutics Appoints Debra Odink, Ph.D., As Chief Development Officer as the Company Advances Novel Pain Drug Candidates 19
Product News 20
11/07/2017: U.S. Department of Defense Awards Grant to SiteOne Therapeutics, Supporting Research and Development of Selective Small Molecule NaV1.7 Inhibitors as Acute and Chronic Pain Therapeutics 20
04/05/2018: Acclaimed Scientists and Physicians Join the Scientific Advisory Board of SiteOne Therapeutics to Help Guide the Advancement of Novel Non-Opioid Pain Therapeutics 21
03/26/2018: SiteOne Therapeutics Announces Abstract Presentation At the Association for Research in Vision and Ophthalmology (ARVO) 22
Clinical Trials 23
Jul 19, 2018: SiteOne Therapeutics to Present Research Findings for Selective Small Molecule Nav1.7 Inhibitors at the 2018 World Congress on Pain 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SiteOne Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SiteOne Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SiteOne Therapeutics Raises USD15 Million in Series B Financing 10
SiteOne Therapeutics Raises Funds through Venture Financing 12
SiteOne Therapeutics Raises USD1.5 Million in Initial Round of Venture Financing 13
SiteOne Therapeutics Enters into R&D Agreement with Amgen 14
SiteOne Therapeutics Inc, Key Competitors 15
SiteOne Therapeutics Inc, Key Employees 16

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

SiteOne Therapeutics Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

SiteOne Therapeutics Inc (SiteOne) is a developer of novel therapeutics and diagnostics for the treatment of acute and chronic pain. The company provides lead therapeutic candidates such as selective inhibitors

USD 250 View Report

SiteOne Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The companys lead therapeutic candidates include ST-2427 Intravenous,

USD 250 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

USD 750 View Report

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available